I thank Kritharides and colleagues1 for their review Cardiovascular disease in patients with schizophrenia. I agree with them and support their work, which seeks to improve the physical health of patients living in the community with a chronic mental illness such as schizophrenia, through an innovative, coordinated and multidisciplinary model of care. Clozapine side effects, including risks of myocarditis and cardiomyopathy, hypercholesterolaemia and weight gain, reduce years of life and require medical attention.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1. Kritharides L, Chow V, Lambert TJR. Cardiovascular disease in patients with schizophrenia. Med J Aust 2017; 206: 91-95. <MJA full text>
- 2. NSW Agency for Clinical Innovation. Rehabilitation resources [website]. Sydney: ACI; 2017. https://www.aci.health.nsw.gov.au/resources/rehabilitation (accessed July 2017).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.